This website uses cookies to ensure you get the best experience on our website. Privacy Policy
UroToday UroToday
  • Contact
  • Login
  • Sign Up Free
  • Transformative Evidence
    • mCRPC
      • The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
      • PROfound
      • VISION Trial
    • mHSPC
      • ARASENS Trial
    • nmCRPC
      • ARAMIS Trial
    • PSMA PET Imaging
      • CONDOR Trial
      • OSPREY Trial
    • Bladder Cancer
      • Bladder Cancer Detection
  • Trials in Progress
    • Trials in Progress
      • Bladder Cancer
        • IMMORTAL
      • Kidney Cancer
        • RadiCal
    • Middle Side
      • Prostate Cancer
        • ARAMON
        • ARASEC
        • ARASTEP
        • ECLIPSE
        • FORT
        • NRG-GU 0101
        • Masofaniten (Oral EPI-7386)
        • RTIRE
        • SHORTER
        • SPLASH
    • Right Side
      • PCCTC
        • DORA
        • IRONMAN
        • PROMISE
  • Centers of Excellence
    • Urologic Oncology
      • Left Group
        • Health Policy
          • Health Policy
            Ruchika Talwar, MD
        • Bladder Cancer
          • Bladder Cancer
            Ashish Kamat, MD
          • Advanced Bladder Cancer
            Petros Grivas, MD
          • Trimodality Therapy
            Leslie Ballas, MD
        • Kidney Cancer
          • Advanced Kidney Cancer
            Pedro Barata, MD, MSc
          • Kidney Cancer Today
            Sumanta (Monty) Kumar Pal, MD
            Jaime Landman, MD
      • Prostate Cancer
        • Advanced Prostate Cancer
          Alicia Morgans, MD, MPH
        • CRPC with Bone Metastases
          Rana R. McKay, MD
        • Imaging Center
          Phillip Koo, MD
        • Localized Prostate Cancer
          Matthew R. Cooperberg, MD, MPH
        • mHSPC
          Alicia Morgans, MD, MPH
        • nmCRPC
          Alicia Morgans, MD, MPH
        • PSMA-Targeted Therapy
      • Disparities: Social Determinants of Health
        • Disparities: Social Determinants of Health
          Samuel L. Washington III, MD, MAS
      • Translational Prostate Cancer
        • Translational Science in Prostate Cancer
          Andrea Miyahira, Ph.D
        • Women in Science
          Andrea Miyahira, Ph.D
      • Upper Tract Urothelial Carcinoma
        • Upper Tract Urothelial Carcinoma
          Sam S. Chang, MD, MBA
      • TESTICULAR, PENILE & RARE GU MALIGNANCIES
        • Testicular, Penile, and Rare GU Malignancies
    • Pelvic Health & Reconstruction
      • Bladder Health
        Diane K. Newman, DNP, ANP-BC, FAAN
      • Pelvic Health
        Diane K. Newman, DNP, ANP-BC, FAAN
      • Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
        Stephen R. Kraus, MD
      • Urologic Catheters (Includes CAUTI)
        Diane K. Newman, DNP, ANP-BC, FAAN
      • Suprapubic Catheter
        Diane K. Newman, DNP FAAN BCB-PMD
  • Videos
    • Exclusives
      • Conferences
      • Exclusive Collaborations
      • Independent Medical Education
      • Covid-19
      • The Prostate Cancer Foundation
    • Urologic Oncology
      • Prostate Cancer
      • Bladder Cancer
      • Kidney Cancer
      • Upper Tract Urothelial Tumors
      • Pelvic Health & Reconstruction
      • Endourology
      • Testicular Cancer
      • Health Policy in Urological Diseases
      • Disparities: Social Determinants of Health
  • Clinical Trials
    • From the Editor
      • Search Clinical Trials
  • Articles
    • Urology (benign and malignant)
      • Urologic Oncology
      • Men's Health
      • Endourology & Stones
      • Pediatric Urology
      • COVID-19 and Genitourinary Cancers
    • Pelvic Health
      • Pelvic Health & Reconstruction
  • Conference Coverage
    • Recent Conferences
      • ASTRO 2023
      • SNMMI 2023
      • ProsTIC/PCF Global Webinar 2023
      • ASCO 2023
      • AUA 2023
    • All Conferences
      • View All
  • PCF
  1. UroToday Home
  2. Recent Abstracts
  3. Urologic Oncology
  4. Bladder Cancer

Conferences

Recent Abstracts
EAU 2012 - The EAUN releases new 2012 Guideline: Catheterisation - Indwelling Catheters in Adults, Urethral and Suprapubic - Session Highlights March 30, 2012
EAU 2012 - Introducing a nurse-led trans-perineal saturation prostate biopsy (TPSBx) service - Session Highlights March 30, 2012
EAU 2012 - Injecting DIGNITY into your neurogenic detrusor overactivity (NDO) patient treatment paradigm: The role of botulinum toxin type A - Session Highlights March 30, 2012
GU Cancers Symposium 2012 - Active surveillance vs. watchful waiting for localized prostate cancer February 15, 2012
WCE 2011 - Flexible ureteroscopy for renal stones >1cm - the method of choice? - Session Highlights February 10, 2012
WCE 2011 - Human versus robot: Who can perform more accurate prostate biopsy? - Session Highlights February 10, 2012
WCE 2011 - Anatomical variation between the prone, supine and supine oblique positions on computed tomography: Implications for percutaneous nephrolithotomy access - Session Highlights February 10, 2012
WCE 2011 - High fidelity team-based simulation training: Laparoscopic renal vein injury scenario - Session Highlights February 10, 2012
WCE 2011 - Portable simulators training enhances the laparoscopic skills acquisition: Randomised controlled trial - Session Highlights February 10, 2012
WCE 2011 - Prospective evaluation of patient satisfaction with treatment outcomes after shock wave lithotripsy and ureteroscopy for ureteral stones - Session Highlights February 10, 2012
WCE 2011 - Prospective evaluation of routine fluorescence cystoscopy demonstrates significantly increased CIS detection - Session Highlights February 10, 2012
WCE 2011 - The CROES Percutaneous Nephrolithotomy Global Study: Urinary tract infections and post-operative fever in percutaneous nephrolithotomy - Session Highlights February 10, 2012
WCE 2011 - What should we measure? Predicting outcomes with flexible ureteroscopy for large renal stones - Session Highlights February 10, 2012
GU Cancers Symposium 2012 - mCRPC opportunities for the urologist and radiation oncologist: An interview with Adam M. Kibel, Chairman, GU Cancers Symposium - Session Highlights February 8, 2012
GU Cancers Symposium 2012 - Prostate cancer: Take home message - Session Highlights February 8, 2012
GU Cancers Symposium 2012 - Radium-223 chloride impact on skeletal-related events in patients with castration-resistant prostate cancer (CRPC) with bone metastases: A phase III randomized trial (ALSYMPCA) - Session Highlights February 8, 2012
GU Cancers Symposium 2012 - Empiric antibiotics for an elevated PSA: A randomized, prospective multiinstitutional trial - Session Highlights February 7, 2012
GU Cancers Symposium 2012 - Validation of a cell-cycle progression (CCP) gene panel to improve risk stratification in a contemporary prostatectomy cohort - Session Highlights February 6, 2012
GU Cancers Symposium 2012 - A phase 1 clinical trial of intravesical antisense oligonucleotide targeting heat shock protein (OGX-427) for the treatment of superficial bladder cancer - Session Highlights February 6, 2012
GU Cancers Symposium 2012 - A phase I clinical trial of intravesical antisense oligonucleotide targeting heat shock protein 27 (OGX-427) for the treatment of superficial bladder cancer - Poster February 6, 2012
Page 509 of 524
  • Start
  • Prev
  • 504
  • 505
  • 506
  • 507
  • 508
  • 509
  • 510
  • 511
  • 512
  • 513
  • Next
  • End
  • About UroToday
  • Journals
  • Calendar
  • Editorial and Advertising Guidelines
  • Editors and Contributors
  • FAQs
  • Privacy Policy
  • Terms of Use
Follow UroToday

COPYRIGHT © 2002 - 2023 DIGITAL SCIENCE PRESS, LLC

Login

Login to update email address, newsletter preferences and use bookmarks.

  • Forgot Password?
  • Sign Up Free